https://asm.org/press-releases/2024/february/65-fellows-elected-into-american-academy-of-microb along with collaborator, Ashlee Earl, Head of the Bacterial Genomics Group, at the Broad Institute, and Brennan-Krohn and Kirby lab collaborator,
Analysis of first pan-drug resistance Neisseria gonorrhoeae isolated in the United States just out in Lancet Infectious Diseases!
ACGME Fellow Matt Hernandez, MD, PhD, presents his genomics and phenotypic antibiotic synergy analysis of carbapenem-resistant, systemic Aeromonas infection at BAARN Meeting
TECAN D300, TECAN M1000 Pro, TECAN Magic Prep, Illumina MiSeq, Qiagen CLC Genomics Workbench, and Matt got a workout! I loved his pulling out NGS reads from rectal swab sample demonstrating bowel colonization with (presumptively) same organism! BAARN 2023 - Boston Area Antimicrobial Resistance Network Meeting.
CPEP Faculty Member, Alex McAdam, on the Election Ballot for President-Elect of the American Society of Microbiology
As if he weren't busy enough as Editor-in-Chief of the Journal of Clinical Microbiology, Alex is on the ballot for President-Elect of ASM. Best wishes, Alex!
BIDMC and Dana Farber Cancer Institute Form New Collaboration with Plan to Build First, Free-Standing, Inpatient Cancer Hospital In New England
More information can be found at the following links:
Micro Attendings Arnaout and Kirby to Speak at November 6th Northeast Branch, ASM Dinner Lecture Series
Learning to Count the Hard Way: Measuring Diversity in the Microbiome and Beyond
presented by: Ramy Arnaout, MD, DPhil
Dr. Arnaout is the Associate Director of the Clinical Microbiology Laboratories at Beth Israel Deaconess Medical Center and Associate Professor of Pathology at Harvard Medical School and President of the ASM Northeast Branch. His research lies at the intersection of computation, immunology, and infectious disease and brings mathematical and physics-based approaches to bear on several problems, including deciphering large-scale antibody and T-cell receptor immunomes.
Today’s talk is about a key tool in the toolkit: measuring diversity in complex systems. Learning to do so led the laboratory on an enlightening (and humbling) journey from immunomes to information theory to microbiomes and beyond.
Staking out new territory on the ribosome for antibiotic development
presented by: James E. Kirby, MD, D(ABMM)
Dr. Kirby is an NIH-funded Principal Investigator in the Experimental Pathology Division of Beth Israel Deaconess Medical Center, Boston, MA, Director of the Clinical Microbiology Laboratory at BIDMC; Program Director of the Medical Microbiology Fellowships at BIDMC; and Professor of Pathology at Harvard Medical School, Boston, MA. He was past president of the Northeast Branch-ASM from 2009-2012.
Dr. Kirby will talk about his collaborative efforts to develop antibiotics targeting gram-negative ESKAPE pathogens. He will discuss the emerging threat from such pathogens; the difficulty in developing new drugs to treat them; and the activity; action; and goals and strategies for development of rediscovered natural products.
https://idweek.org/events/bugbowl/Congratulations, BIDMC ID Fellows - Winners of the 2023 IDWeek IDBugBowl!
Delighted that Nouf Almaghlouth, M.D., M.P.H., will be joining us as our 2025 ACGME Medical Microbiology Fellow!
Colette Matysiak's manuscript on the Abbott Alinity m STI test published in Practical Laboratory Medicine
Colette was busy during her 3-month clinical microbiology rotation at BIDMC prior to moving on to a CPEP fellowship at UCLA. Here manuscript validating the performance of the Abbott Alinity m STI test (a quadriplex assay simultaneously detecting Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium inclusive of sampling and internal controls) was recently published in Practical Laboratory Medicine. We are delighted to be part of the early launch of several clinical microbiology careers and wish Dr. Matysiak well in her fellowship training and beyond!
Here is the reference and full text link: Matysiak C, Cheng A, Kirby JE. Evaluation of the Abbott Alinity m STI assay for diagnosis of the primary causes of sexually transmitted infections in the United States. Pract Lab Med. 2023 Aug 22;36:e00332. doi: 10.1016/j.plabm.2023.e00332. PMID: 37705589; PMCID: PMC10495529.